Medicare shakeup spurs cost warnings, urgent plan switches

The fall 2026 Medicare open-enrollment season was the decision window because it is the period when beneficiaries can actually act on what they learn about 2027 coverage. As the Explainer put it, “Medicare Open Enrollment, which runs from October 15 through December 7, lets you freely switch Advantage plans,” and “During that period, a beneficiary can join, switch or drop a Medicare Advantage plan”; likewise, “Medicare's Annual Enrollment Period runs October 15 through December 7,” and during that window beneficiaries can switch Part D drug plans or move between Original Medicare and Medicare Advantage.

What made that window urgent in October and November 2026 was not timing alone but the stream of new information showing that passive renewal could be costly in 2027. Diane Amdahl said beneficiaries should expect plans “going away” and “premiums increasing,” while advisers urged people to “run prescriptions through Medicare.gov's Plan Finder every year,” because “a single drug moving from tier 2 to tier 4 can add hundreds in costs”; Amdahl’s example was a client whose plan rose from “$22 a month” to “$169 a month” after he ignored annual notices.

The cost squeeze starts with Medicare’s basic math: beneficiaries are paying more before they receive much care, and those exposures are not theoretical. Yahoo Finance reported that for 2027, “The Part B premium is projected to increase by $6.60 to $209.50,” while “The Part B deductible will rise from $283 in 2026 to a projected range between $292 and $310,” and Suze Orman’s retirement-cost warning noted that “in 2026, patients face a $1,736 deductible for each inpatient benefit period” — a serious risk given CDC data showing 16.9% of Americans ages 65 to 74 had at least one hospital stay in 2019, rising to 26.1% among those 85 and older.

Drug coverage is adding another layer of pressure, because 2027 brings both higher plan costs and the end of federal help that had softened them. Yahoo Finance said “The Part D standard deductible is forecast to increase from $615 to $700,” while “The subsidies reduced PDP premiums by $16 in 2026,” and KFF Health News summed up the direction plainly: “Medicare Drug Plans Are Hiking Premiums”; that helps explain why a TIAA survey found 77% fear the $202.90 Medicare Part B premium will cut retirement income, as beneficiaries weigh whether their current mix of Medicare and drug coverage still protects them from mounting out-of-pocket risk.

The shape of 2027 coverage is changing at the product level, not just around the edges. Becker’s Healthcare Podcast underscored that the October 1 release of Medicare Advantage plan information came with market shifts, a sign that insurers are altering their 2027 offerings enough that beneficiaries need to review options rather than assume continuity, while PR Newswire highlighted how benefit design itself is moving, with the headline “NCD Launches Dental Comparison Tool Amid 31% Cut in Medicare Advantage Benefits for 2027,” showing why even familiar plans may no longer deliver the same package of services.

Those portfolio changes also extend to what plans cover and how they price drugs, making blind renewal especially risky. Fed Gov Today said “Premiums just increased” and warned that “the formularies, the difference between tier 2, tier three, and tier four formularies, GLP1s, can be very dramatic,” including an example of “$50 versus 50%,” while also noting that “one plan in particular saw an increase on their member plus one p plan over 100%,” evidence that 2027 offerings can differ materially from the plans beneficiaries think they already know.

Switching is increasingly a defensive move because the real risk is not just paying more, but staying in coverage that no longer shields against large bills. Briefglance’s cited survey found 88% of beneficiaries do not realize Original Medicare has “no annual cap on out-of-pocket costs,” meaning a major illness can leave them owing 20% with costs that can run into “tens or even hundreds of thousands of dollars,” while a “one-time, six-month Medigap Open Enrollment Period” may be the only guaranteed chance to add protection before health status or price becomes a barrier.

What makes inaction especially dangerous is that many beneficiaries think they understand Medicare well enough to coast, even as missed decisions can harden into lasting cost exposure. The same analysis said 89% of current beneficiaries feel confident even though that confidence is “dangerously misplaced,” and among adults 55 to 64, 88% do not know delaying Part B can trigger a “permanent penalty—a 10% premium increase for every 12-month period of delay,” while 80% are unaware of a Part D late penalty; InvestTalk added that optimizing can be worth “upwards of $1,000 a month of benefits per person.”